| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/18/2004 | DE10240866A1 New polypeptide that binds immunoglobulin E and alters cytokine synthesis, useful for treating e.g. atopic eczema, asthma or allergy, also its encoding nucleic acid |
| 03/18/2004 | DE10130985B4 Verfahren zur Diagnose von Sepsis und schweren Infektionen unter Bestimmung löslicher Cytokeratin-1-Fragmente A method for the diagnosis of sepsis and severe infections by determining soluble cytokeratin-1 fragments |
| 03/18/2004 | CA2498297A1 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | CA2497902A1 Smg-1 binding protein and screening method for substances that can regulate the activity thereof |
| 03/18/2004 | CA2497833A1 A method of modulating cellular activity and molecules for use therein |
| 03/18/2004 | CA2497788A1 Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
| 03/18/2004 | CA2497750A1 Orthopoxvirus vectors, genes and products thereof |
| 03/18/2004 | CA2497696A1 Increasing the absorption of substances via the skin and mucous membranes |
| 03/18/2004 | CA2497660A1 Allergy vaccines |
| 03/18/2004 | CA2497644A1 Whole bacterial cells as immune modulator |
| 03/18/2004 | CA2496888A1 Epitope sequences |
| 03/18/2004 | CA2496596A1 Cancer therapy using yeast insoluble .beta.-glucan particles and antibodies |
| 03/18/2004 | CA2496566A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/18/2004 | CA2495825A1 Variants of the major allergen phl p 1 from timothy grass |
| 03/18/2004 | CA2495480A1 Interferon and immunoglobulin fc fragment hybrid |
| 03/18/2004 | CA2441469A1 Methods and compositions for treating alzheimer's disease |
| 03/18/2004 | CA2407301A1 Hsp60 sequence from piscirickettsia salmonis |
| 03/17/2004 | EP1398380A1 Orthopoxvirus antigens and use thereof |
| 03/17/2004 | EP1398379A2 Compounds for immunotherapy and diagnosis of tuberculosis |
| 03/17/2004 | EP1398377A1 Growth differentation Factor-7 |
| 03/17/2004 | EP1398371A1 Infectious HCV pseudo-particles containing functional E1, E2 envelope proteins |
| 03/17/2004 | EP1398038A1 Botulinum toxin pharmaceutical compositions |
| 03/17/2004 | EP1397507A1 Methods and compositions for treating cardiovascular disease using 10218 |
| 03/17/2004 | EP1397500A2 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation |
| 03/17/2004 | EP1397498A1 Delections in arterivirus replicons |
| 03/17/2004 | EP1397488A1 Novel compounds for chemiluminescense procedures |
| 03/17/2004 | EP1397486A2 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 03/17/2004 | EP1397383A2 Secreted polypeptide and their use in the treatment of bone disorders |
| 03/17/2004 | EP1397159A2 Stable liquid formulations of antibodies |
| 03/17/2004 | EP1397158A2 USE OF IgM ANTIBODIES AGAINST dsDNA IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS |
| 03/17/2004 | EP1397157A2 Antibacterial agent |
| 03/17/2004 | EP1397122A1 Solid form immunity adjuvant and vaccine containing same |
| 03/17/2004 | EP1397043A2 Methods for genetic immunization |
| 03/17/2004 | EP0973546B1 Stabilized human papillomavirus formulations |
| 03/17/2004 | EP0970107B1 Cyclosporine derivatives and uses thereof |
| 03/17/2004 | EP0946590B1 Dihydroxypropyl cysteine peptide and agent containing this peptide |
| 03/17/2004 | EP0866655B1 Murine model for human carcinoma |
| 03/17/2004 | EP0825885B1 Pulmonary delivery of aerosolized medicaments |
| 03/17/2004 | EP0762881B1 Use of active agents for the manufacture of medicaments for the treatment of rheumatoid arthritis |
| 03/17/2004 | CN1483079A Immunoregulation polynucleotide and using method thereof |
| 03/17/2004 | CN1482916A Vaccine composite containing invert growth factor a |
| 03/17/2004 | CN1482861A Method of sterilizing antibody-containing milk and products containing sterilized antibody-containing milk by filtration to remove bacteria |
| 03/17/2004 | CN1482249A Eukaryotic expression vector of ER-detented IV collagenase cellular antibody gene |
| 03/17/2004 | CN1482243A Acquistion of nasopharyngeal cancer relatived gene NGX6 expression product and preparation of antibody |
| 03/17/2004 | CN1482141A Method for preparing specific composite IgY against periodontal disease and group system thereof |
| 03/17/2004 | CN1482140A Process for extracting medicinal protein from ostrich blood and use thereof |
| 03/17/2004 | CN1481900A Specific IgY and composite IgY for Rheum and its novel formulation |
| 03/17/2004 | CN1481899A Novel vaccine of tumor antigen, its preparation method and vaccine composition |
| 03/17/2004 | CN1481898A Vaccine preparation for fused virus-like granule, its production method and process of using |
| 03/17/2004 | CN1142277C Method for identifying toxicity attenuated chickenpox virus OKA strain |
| 03/17/2004 | CN1142271C Toxicity attenuated Japanese encephalitis virus adapted to vero cell and vaccine thereof |
| 03/17/2004 | CN1142183C Anti-idiotype microantibody and its preparing process and application |
| 03/17/2004 | CN1142177C Isolated MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 03/17/2004 | CN1141977C Improved virus vaccine |
| 03/17/2004 | CN1141976C Inactivated clostridium perfringens disease vaccine for ox and its preparation |
| 03/17/2004 | CN1141975C Process for preparing xenogenous or autogenous tumor vaccine of liposome |
| 03/16/2004 | US6706873 Nucleic acid molecule encoding specified amino acid sequence |
| 03/16/2004 | US6706859 HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV |
| 03/16/2004 | US6706693 Vaccination by topical application of genetic vectors |
| 03/16/2004 | US6706687 Platelet-derived growth factor D |
| 03/16/2004 | US6706523 Nucleoprotein is mutated at the amino acid wherein phosphorylation occurs |
| 03/16/2004 | US6706514 Polypeptides capable of interacting with the human topoisomerase IIIα |
| 03/16/2004 | US6706508 Isolated polypeptide comprising specified amino acid sequence, which exhibits ornithine carbamoyltransferase activity |
| 03/16/2004 | US6706494 Isolated recombinant polypeptide comprising specified amino acid sequence or immunogenic fragment comprising at least 15 contiguous amino acids, which induces antibody- or t-cell mediated immune response that recognizes polypeptide |
| 03/16/2004 | US6706488 Antigenic compound for use in the treatment,and diagnosis of cancer |
| 03/16/2004 | US6706271 Cloning of BASB023 antigen from Moraxella catarrhalis |
| 03/16/2004 | US6706270 Compounds |
| 03/16/2004 | US6706269 Moraxella catarrhalis PILQ proteins |
| 03/16/2004 | US6706268 Human deficiency virus type-1 (HIV-1) peptide encoded by the VIF gene |
| 03/16/2004 | US6706266 Oncostatin M antagonists |
| 03/16/2004 | US6706265 Immunosuppressing graft rejection |
| 03/16/2004 | US6706262 Compounds and methods for therapy and diagnosis of lung cancer |
| 03/16/2004 | US6706261 Compositions and methods comprising immunogenic muteins of interleukin-6 |
| 03/16/2004 | US6705556 Composition and method for inducing tolerance to viral infection in aquatic animals |
| 03/16/2004 | CA2262500C Measles virus mutant antigen and gene coding for the same |
| 03/16/2004 | CA2234204C Novel antibody, renin-active substance containing the same and prorenin assay reagent using the same |
| 03/16/2004 | CA2100709C Method and means for site directed therapy |
| 03/11/2004 | WO2004021010A2 Method of diagnosing colon and gastric cancers |
| 03/11/2004 | WO2004020643A2 Regulated bacterial lysis for gene vaccine vector delivery and antigen release |
| 03/11/2004 | WO2004020634A1 Mutant forms of meningococcal adp-ribosylating toxin |
| 03/11/2004 | WO2004020624A1 Cancer antigens and utilization thereof |
| 03/11/2004 | WO2004020618A1 Streptococccus suis surface proteins, ornithine carbamolytransferase and arginine deiminase, expressed under stress conditions |
| 03/11/2004 | WO2004020610A2 Methods and compositions for modulating xbp-1 activity |
| 03/11/2004 | WO2004020609A2 Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection |
| 03/11/2004 | WO2004020605A2 Circular nucleic acid vectors, and methods for making and using the same |
| 03/11/2004 | WO2004020592A2 Retroductal salivary gland genetic vaccination |
| 03/11/2004 | WO2004020585A2 Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry |
| 03/11/2004 | WO2004020579A2 Method of humanizing immune system molecules |
| 03/11/2004 | WO2004020471A1 Recombinant protein for preventing human chlamydia trachomatis and the uses thereof |
| 03/11/2004 | WO2004020463A2 Mutant protein and refolding method |
| 03/11/2004 | WO2004020452A2 Method for refolding neisserial nspa protein |
| 03/11/2004 | WO2004020451A1 Group b streptococcal phage lysin |
| 03/11/2004 | WO2004020406A2 Variants of vibrio cholerae o1 biotype e1 tor with attributes of classical biotype |
| 03/11/2004 | WO2004020404A2 Modified transferin-antibody fusion proteins |
| 03/11/2004 | WO2004020014A2 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 03/11/2004 | WO2004019979A2 Vaccine comprising il-13 and an adjuvant |
| 03/11/2004 | WO2004019978A1 Recombinant nucleic acid useful for inducing protective immune response against allergens |
| 03/11/2004 | WO2004019977A2 Improved bacterial outer membrane vesicles |
| 03/11/2004 | WO2004019976A2 Pharmaceutical liposomal compositions containing n. meningitidis derived polypeptides or polynucleotides |
| 03/11/2004 | WO2004019975A2 Il-14 vaccine for the treatment of asthma and atopic disorders |